The global tardive dyskinesia therapeutics market is poised for steady growth over the coming years, reflecting an increasing focus on patient-centric care and the rising prevalence of antipsychotic-induced movement disorders. Tardive dyskinesia (TD), a neurological disorder characterized by involuntary, repetitive body movements, has become a growing concern among patients undergoing long-term...
The global Tardive Dyskinesia (TD) treatment market is projected to reach USD 6.6 billion by 2034, up from USD 3.6 billion in 2024, growing at a CAGR of 6.3% during the forecast period from 2025 to 2034. This growth is mainly due to increasing awareness and improved diagnosis of the disorder. TD is a serious neurological condition that leads to involuntary and repetitive movements. These...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek